AbbVie Inc. (ABBV) stock
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)
Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%
AbbVie gross margin
Gross margin is gross profit as a percentage of revenue.
AbbVie's gross margin for the twelve months ending Jun 30, 2026 was 71.5%. For fiscal 2025 it was 70.2%, against 70.0% the year before. The highest annual figure on record is 80.3% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.2% | +0.2 |
| FY2024 | Dec 31, 2024 | 70.0% | +7.6 |
| FY2023 | Dec 31, 2023 | 62.4% | −7.6 |
| FY2022 | Dec 31, 2022 | 70.0% | +1.0 |
| FY2021 | Dec 31, 2021 | 69.0% | +2.5 |
| FY2020 | Dec 31, 2020 | 66.4% | −11.2 |
| FY2019 | Dec 31, 2019 | 77.6% | +1.2 |
| FY2018 | Dec 31, 2018 | 76.4% | +1.4 |
| FY2017 | Dec 31, 2017 | 75.0% | −2.2 |
| FY2016 | Dec 31, 2016 | 77.3% | −3.1 |
| FY2015 | Dec 31, 2015 | 80.3% | +2.5 |
| FY2014 | Dec 31, 2014 | 77.8% | +2.2 |
| FY2013 | Dec 31, 2013 | 75.6% | +0.1 |
| FY2012 | Dec 31, 2012 | 75.5% | +2.1 |
| FY2011 | Dec 31, 2011 | 73.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 74.7% | +2.9 |
| Q1 FY2026 | Mar 31, 2026 | 71.9% | +1.9 |
| Q4 FY2025 | Dec 31, 2025 | 72.6% | +1.7 |
| Q3 FY2025 | Sep 30, 2025 | 66.4% | −4.5 |
| Q2 FY2025 | Jun 30, 2025 | 71.8% | +0.9 |
| Q1 FY2025 | Mar 31, 2025 | 70.0% | +3.3 |
| Q4 FY2024 | Dec 31, 2024 | 70.9% | +10.8 |
| Q3 FY2024 | Sep 30, 2024 | 70.9% | +17.4 |
| Q2 FY2024 | Jun 30, 2024 | 70.9% | +1.5 |
| Q1 FY2024 | Mar 31, 2024 | 66.7% | −0.7 |
| Q4 FY2023 | Dec 31, 2023 | 60.1% | −12.3 |
| Q3 FY2023 | Sep 30, 2023 | 53.4% | −12.7 |
| Q2 FY2023 | Jun 30, 2023 | 69.4% | −2.0 |
| Q1 FY2023 | Mar 31, 2023 | 67.4% | −2.7 |
| Q4 FY2022 | Dec 31, 2022 | 72.4% | +1.4 |
| Q3 FY2022 | Sep 30, 2022 | 66.1% | −3.3 |
| Q2 FY2022 | Jun 30, 2022 | 71.4% | +3.8 |
| Q1 FY2022 | Mar 31, 2022 | 70.1% | +2.5 |
| Q4 FY2021 | Dec 31, 2021 | 71.0% | +4.8 |
| Q3 FY2021 | Sep 30, 2021 | 69.4% | +8.5 |
| Q2 FY2021 | Jun 30, 2021 | 67.6% | +3.2 |
| Q1 FY2021 | Mar 31, 2021 | 67.6% | −9.9 |
| Q4 FY2020 | Dec 31, 2020 | 66.2% | −10.8 |
| Q3 FY2020 | Sep 30, 2020 | 60.9% | −16.5 |
| Q2 FY2020 | Jun 30, 2020 | 64.4% | −13.6 |
| Q1 FY2020 | Mar 31, 2020 | 77.5% | −0.9 |
| Q4 FY2019 | Dec 31, 2019 | 77.0% | +1.3 |
| Q3 FY2019 | Sep 30, 2019 | 77.4% | −0.4 |
| Q2 FY2019 | Jun 30, 2019 | 78.0% | +1.3 |
| Q1 FY2019 | Mar 31, 2019 | 78.4% | +2.6 |
| Q4 FY2018 | Dec 31, 2018 | 75.7% | +5.1 |
| Q3 FY2018 | Sep 30, 2018 | 77.7% | +0.8 |
| Q2 FY2018 | Jun 30, 2018 | 76.6% | −1.3 |
| Q1 FY2018 | Mar 31, 2018 | 75.7% | +0.4 |
| Q4 FY2017 | Dec 31, 2017 | 70.5% | −6.6 |
| Q3 FY2017 | Sep 30, 2017 | 76.9% | +0.3 |
| Q2 FY2017 | Jun 30, 2017 | 78.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 75.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 77.1% | – |
| Q3 FY2016 | Sep 30, 2016 | 76.6% | – |
See a number that looks wrong?